COMMUNIQUÉS West-GlobeNewswire

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2017

15/09/2017 - 17:00

Communiqué de presse Villepinte, le 15 septembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Shire Debuts MYDAYIS® and New Research at the 30th Annual Psych Congress

15/09/2017 - 13:00

Shire Debuts MYDAYIS ® and New Research at the 30 th Annual Psych Congress Lexington, MA - September 15, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) will share new Attention Deficit Hyperactivity Disorder (ADHD) research [...]

Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of death

15/09/2017 - 09:31

PR170915_EASD_Tresiba_UK This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Solon Eiendom ASA : Primary insider notification

15/09/2017 - 08:30

(Oslo, Norway, 14 September 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 25 373 shares in Solon Eiendom ASA at a price of NOK 17,5908. Following [...]

Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease

15/09/2017 - 08:00

Press release Malmö, September 15, 2017 Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease The company's roll-out program on track as [...]

FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017

15/09/2017 - 08:00

FIT Biotech Oy Company release September 15th, 2017 at 9:00 EET FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017 (unaudited) This company release is a summary of FIT Biotech's Half Year Financial [...]

Herantis Pharma receives Life Sciences Nordic Stars Award

15/09/2017 - 07:30

Herantis Pharma receives Life Sciences Nordic Stars Award Herantis Pharma Plc Press release 15 Sep 2017 at 8:30 am Herantis Pharma plc ("Herantis") received the Nordic Stars Award at the Nordic Life Sciences Days in [...]

Fagron NV: Disclosure of received notification

15/09/2017 - 07:00

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands) 1 , 15 September 2017 Disclosure of received notification Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in [...]

Santhera Receives Negative Opinion from the CHMP for its Marketing Authorization Application for Raxone® in DMD and Intends to Appeal this Opinion

15/09/2017 - 07:00

Liestal, Switzerland, September 15, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative [...]

Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic's Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer

14/09/2017 - 22:01

Conference call scheduled for 2:00 PM CEST / 8:00 AM EDT tomorrow, Friday, September 15 COPENHAGEN, Denmark, September 14, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that an independent Data [...]

AB Science annonce que le CHMP a adopté une opinion négative pour l'enregistrement du masitinib dans la mastocytose systémique indolente après réévaluation du dossier

14/09/2017 - 18:47

Paris, 14 septembre 2017, 18h30 AB Science annonce que le CHMP a adopté une opinion négative pour l'enregistrement du masitinib dans la mastocytose systémique indolente, après réévaluation du dossier AB Science SA (NYSE [...]

AB Science announces that CHMP adopted a negative opinion for masitinib marketing authorization in indolent systemic mastocytosis after reassessment

14/09/2017 - 18:47

Paris, 14 September 2017, 6.30pm AB Science announces that CHMP adopted a negative opinion for masitinib marketing authorization in indolent systemic mastocytosis after reassessment AB Science SA (NYSE Euronext - [...]

Guerbet annonce que Vectorio®, un dispositif médical innovant pour les procédures cTACE, a reçu le marquage CE

14/09/2017 - 18:02

Vectorio ® sera présenté lors des prochains congrès de radiologie Villepinte (France), le 14 septembre 2017 (18 heures CEST) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour [...]

Guerbet Announces CE Mark for Vectorio®, An Innovative Medical Device for cTACE Procedures

14/09/2017 - 18:02

Vectorio ® will be presented at the upcoming radiology congresses Villepinte (France), September 14, 2017 (6:00 PM CEST) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical [...]

Nestlé acquires majority interest in Blue Bottle Coffee

14/09/2017 - 18:01

This press release is also available in Français (pdf) and Deutsch (pdf) ....................................... Vevey, 14 September 2017 Nestlé acquires majority interest in Blue Bottle Coffee Nestlé today announced [...]

Increase of Nexstim Plc's share capital with subscriptions based on stock options 2013A

14/09/2017 - 18:00

Company announcement, Helsinki, 14 September 2017, at 7 PM Increase of Nexstim Plc's share capital with subscriptions based on stock options 2013A Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a [...]

La plateforme d'oncologie intégrée de CrownBio permet d'anticiper l'immunothérapie HERA GITRL prometteuse d'Apogenix pour le CPNPC et le cancer des voies aérodigestives supérieures

14/09/2017 - 17:25

SANTA CLARA, Californie, le 13 septembre 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services [...]

Medtronic Announces Inaugural 2017 Global Champions Team

14/09/2017 - 17:00

Athletes from Five Continents Benefitting from Medical Technology Will Showcase Remarkable Spirit at the Medtronic Twin Cities Marathon and Medtronic TC 10 Mile Events This October DUBLIN - September 14, 2017 - Long [...]

Targovax Receives 2017 Nordic Stars Award

14/09/2017 - 16:00

Oslo, Norway, 14 September 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that they are one [...]